跳至主要内容
临床试验/PACTR202405917242393
PACTR202405917242393尚未招募3 期

Effectiveness and Safety Dosing of Sodium Bicarbonate in Women with Obstructed Labor in Eastern Uganda: A Phase III Randomized placebo-controlled Trial (SoBicOL- II Study)

Busitema University0 个研究点目标入组 280 人开始时间: 2024年5月18日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • We will include patients with obstructed labour carrying singleton, term pregnancies (=37 weeks of gestation) in cephalic presentation.

排除标准

  • We will exclude patients with other obstetric emergencies such as antepartum haemorrhage, preeclampsia and eclampsia (defined as elevated blood pressure of at least 140/90 mm Hg, urine protein of at least 2+, any of the danger signs and fits), premature rupture of membranes and intrauterine fetal death.
  • Patients with comorbidities such as diabetes mellitus, sickle cell disease, renal disease, liver disease and heart disease.
  • We will also exclude those patients with hypokalaemia (148 mmol/L) and alkalosis (bicarbonate >22 mmol/L) because they are more likely to develop adverse drug reactions

研究者

发起方
Busitema University

相似试验